Homeopathic Pharmacists Association Highlights the Extraordinary Safety Record of Homeopathic Medicines
While the causal relationship between intranasal zinc preparations and anosmia is examined in a study published in the July 2010 issue of Archives of Otolaryngology-Head & Neck Surgery, the study’s practical application on public health is reduced to supporting action taken the following summer by the U.S. Food and Drug Administration (FDA) in removing related products from the marketplace.
Contrary to the position taken by Terrance M. Davidson, M.D., and Wendy M. Smith, M.D. in their recently published study, “The Bradford Hill Criteria and Zinc-Induced Anosmia,” action by the FDA against products containing intranasal zinc gluconate demonstrates the agency’s competency in regulating homeopathic medicines to protect the public’s health.
Drs. Davidson and Smith of the University of California evaluated 25 patients who apparently developed anosmia after using intranasal zinc gluconate, as well as reports of clinical, biological and experimental data. Beyond showing that zinc was the causative agent, Davidson and Smith then presumed that the system needs strengthening rather than acknowledging its success last summer. In fact, the FDA had monitored the reported cases of claimed zinc-induced anosmia and took appropriate action in a judicious manner—an action supported by the American Association of Homeopathic Pharmacists to protect public health.
Homeopathic medications are regulated by the FDA and have been used safely in the United States since before the passage of the Federal Food, Drug, and Cosmetic Act in 1938. Homeopathic medicines have an extraordinary record of safety. FDA’s Compliance Policy Guide (CPG 400.400) “Conditions Under Which Homeopathic Drugs May Be Marketed” has been an effective and workable way to regulate homeopathic drugs since 1988.